Biochemical and cognitive impairments observed in animal models of schizophrenia induced by prenatal stress paradigm or methylazoxymethanol acetate administration

• Autorzy: Ratajczak P. , Kus K. , Murawiecka P. , Slodzinska I. , Giermaziak W. , Nowakowska E.
• Języki publikacji: EN

Abstrakty

EN

The aim of the study was to find whether spatial memory impairment and disruption in locomotor activity were found in prenatally stressed rats (PSG) or prenatally methylazoxymethanol acetate-treated rats (MAMG). In addition to this, we examined basal plasma corticosterone level as well as brain-derived neurothropic factor (BDNF) in the PSG and MAMG rats. The effect of prenatal stress (stress paradigm between 14 and 21 day of gestation) and methylazoxymethanol acetate (MAM) administration (17 day of gestation) to the female Wistar rats were studied on the male offspring in the Morris Water Maze (spatial memory) and locomotor activity test. Through Morris Water Maze rats were injected with saline 4 times (on 7, 14 and 21 day of testing) while in locomotor activity test saline was injected only once. Corticosterone level was measured using ELISA Kit while BDNF levels were assessed using ELISA Chemikine TM BDNF kit. Results indicate that both PSG and MAMG rats deteriorate spatial memory as well as increase locomotor activity compared to the control group. Biochemical studies indicate that basal plasma corticosterone level increased in both PSG and MAMG rats compared to the control group. Analyses of the BDNF level, on the other hand, have shown decrease of the neurothropin level in both hippocampus and prefrontal cortex (PFC) in both PSG and MAMG groups of rats. As shown by the obtained results, both the prenatal stress model and prenatal MAM administration model generate a number of behavioral (e.g. spatial memory disorders, increased locomotor activity) and biochemical (e.g. increased corticosterone and decreased BDNF levels) changes in the examined offspring, Thus, these models can be successfully used in the efficacy analysis of the pharmacotherapy applied.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2015
• Tom: 75
• Numer: 3
• Opis fizyczny: p.314-325,fig.,ref.

Twórcy

autor

Ratajczak P.

• Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland

autor

Kus K.

• Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland

autor

Murawiecka P.

• Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland

autor

Slodzinska I.

• Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland

autor

Giermaziak W.

• Polish Central Medical Library, Warsaw, Poland

autor

Nowakowska E.

• Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland

Bibliografia

• Addington J, Addington D (2000) Neurocognitive and social functioning in schizophrenia: a 2,5 year follow-up study. Schizophr Res 44(1): 47-56.
• Aksic M, Radonjic NV, Aleksic D, Jevtic G, Markovic B, Petronijevic N, Radonjic V, Filipovic B (2013) Long-term effects of the maternal deprivation on the volume and number of neurons in the rat neocortex and hippocampus. Acta Neurobiol Exp (Wars) 73(3): 394-403.
• Alleva E, Aloe L, Bigi S (1993) An updated role for nerve growth factor in neurobehavioural regulation of adult vertebrates. Rev Neurosci 4: 41-62.
• Arnold SE, Trojanowski JQ (1996) Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol 92: 217-231.
• Balduini W, Lombardelli G, Peruzzi G, Cattabeni F (1991) Treatment with methylazoxymethanol at different gesta- tional days: Physical, reflex development and spontane¬ous activity in the offspring. Neurotoxicology 12: 179¬188.
• Bersani G, Aloe L, Iannitelli A (1999) Low nerve growth factor plasma levels in schizophrenic patients: A pilot study. Schizophr Res 18: 159-160.
• Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, Frank JA, Tedeschi G, Weinberger DR (1996) Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice pro¬ton magnetic resonance spectroscopic imaging. Am J Psychiatry 153: 1554-1563.
• Calabrese F, Luoni A, Guidotti G, Racagni G, Fumagalli F, Riva MA (2013) Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid. Psychopharmacology (Berl) 226(1): 101-112.
• Cannon-Spoor HE, Freed WJ (1984) Hyperactivity induced by prenatal administration of methylazoxymethanol: Association with altered performance on conditioning tasks in rats. Pharmacol Biochem Behav 20: 189-193.
• Cattabeni F, Di Luca M (1997) Developmental models of brain dysfunctions induced by targeted cellular ablations with methylazoxymethanol. Physiol Rev 77: 199-215.
• Chao MV (2000) Trophic factors: an evolutionary cul-de-sac or door into higher neuronal function? J Neurosci Res 59: 353-355.
• Charmandari E, Kino T, Souvatzoglou E, Chrousos GP (2003) Pediatric stress: hormonal mediators and human development. Horm Res 59: 161-179
• Chevassus-Au-Louis N, Congar P, Represa A, Ben-Ari Y, Gaiarsa JL (1998) Neuronal migration disorders: hetero¬topic neocortical neurons in CA1 provide a bridge between the hippocampus and the neocortex. Proc Natl Acad Sci U S A 95: 10263-10268.
• Connor B, Dragunow M (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 27: 1-39.
• Conrad CD, LeDoux JE, Magarinos AM, Mc Ewen BS (1999) Repeated restraint stress facilitates fear condition¬ing independently of causing Hippocampal CA3 dendritic athropy. Behav Neurosci 113(5): 902-913.
• Conrad CD, McLaughlin KJ, Harman JS, Foltz C, Wieczorek L, Lightner E, Wright RL (2007) Chronic glucocorticoids increase hippocampal vulnerability to neurotoxicity under conditions that produce CA3 dendritic retraction but fail to impair spatial recognition memory. J Neurosci 27: 8278-8285.
• Corcoran C, Gallitano A, Leitman D, Malaspina D (2001) The neurobiology of the stress cascade and its potential relevance for schizophrenia. J Psychiatr Pract 7: 3-14.
• Di Fausto V, Fiore M, Aloe L (2007) Exposure in fetus of methylazoxymethanol in the rat alters brain neurotrophins' levels and brain cells' proliferation. Neurotoxicol Teratol 29(2): 273-281.
• Ebendal T (1989) NGF in CNS: experimental data and clinical implications. Prog Growth Factor Res 1: 143¬159.
• Featherstone RE, Burton CL, Coppa-Hopman R, Rizos Z, Sinyard J, Kapur S, Fletcher PJ (2009) Gestational treat¬ment with methylazoxymethanol (MAM) that disrupts hippocampal-dependent memory does not alter behav¬ioural response to cocaine. Pharmacol Biochem Behav 93(4): 382-390
• Featherstone RE, Rizos Z, Nobrega JN, Kapur S, Fletcher PJ (2007) Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophre¬nia. Neuropsychopharmacology 32(2): 483-492.
• Ferguson SA, Racey FD, Paule MG, Holson RR (1993) Behavioral effects of methylazoxymethanol-induced micrencephaly. Behav Neurosci 107: 1067-1076.
• Fiore M, Korf J, Antonelli A, Talamini L, Aloe L (2002) Long-lasting effects of prenatal MAM treatment on water maze performance in rats: associations with altered brain development and neurotrophin levels. Neurotoxicol Teratol 24(2): 179-191.
• Fiore M, Talamini L, Angelucci F, Koch T, Aloe L, Korf J (1999) Pharmacologically-induced damage in the entorhinal cortex alters behavior and brain NGF levels in young rats: A possible correlation with the development of schizophrenia-like deficits. Neuropharmacology 38: 857-869.
• Flagstad P, Glenthoj BY, Didriksen M (2005) Cognitive deficits caused by late gestational disruption of neurogen- esis in rats: a preclinical model of schizophrenia. Neuropsychopharmacology 30(2): 250-260.
• Gabryel B (2008) Disturbance of the Wnt signaling pathway in the pathogenesis of schizophrenia (in Polish). Neuropsychologia i Neuropsychiatria 3(3-4): 133-140.
• Gourevitch R, Rocher C, Le Pen G, Krebs MA, Jay TM (2004) Working memory deficits in adult rats after prena¬tal disruption of neurogenesis. Behav Pharmacol 15: 287-292.
• Gulley JM, Kuwajima M, Mayhill E, Rebec GV (1999) Behavior-related changes in the activity of substantia nigra pars reticulata neurons in freely moving rats. Brain Res 845: 68-76.
• Hanada S, Nakatsuka T, Hayasaka I, Fujii T (1982) Effects of prenatal treatment with methylazoxymethanol acetate on growth, development, reproductive performance, learning ability, and behavior in the rat offspring. J Toxicol Sci 7: 93-110.
• Harrison PJ (1999) The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122(4): 593-624.
• Heckers S (2001) Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 11: 520-528.
• Hintze B, Wciorka J, Borkowska A (2007) Working memory and executive functions disorders in schizophrenic patients in partial remission of psychopathological symp¬toms (in Polish). Psychiatria 4(2): 45-52.
• Hradetzky E, Sanderson TM, Tsang TM (2012) The methy- lazoxymethanol acetate (MAM-E17) rat model: molecu¬lar and functional effects in the hippocampus. Neuropsychopharmacology 37(2): 364-377.
• Karnam HB, Zhao Q, Shatskikh T, Holmes GL (2009a) Effect of age on cognitive sequelae following early life seizures in rats. Epilepsy Res 85: 221-230.
• Karnam HB, Zhou JL, Huang LT, Zhao Q, Shatskikh T, Holmes GL (2009b) Early life seizures cause long-stand¬ing impairment of the hippocampal map. Exp Neurol 217: 378-387.
• Karten YJ, Olariu A, Cameron HA (2005) Stress in early life inhibits neurogenesis in adulthood. Trends Neurosci 28: 171-172.
• Kinnunen AK, Koenig JI, Bilbe G (2003) Repeated variable prenatal stress alters pre- and postsynaptic gene expres¬sion in the rat frontal pole. J Neurochem 86: 736-748.
• Koenig JI, Elmer GI, Shepard PD, Lee PR, Mayo C, Joy B, Hercher E, Brady DL (2005) Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behav Brain Res 156: 251-261.
• Lee PR, Brady DL, Shapiro RA, Dorsa DM, Koenig JI (2007) Prenatal stress generates deficits in rat social behavior: reversal by oxytocin. Brain Res 1156: 152¬167.
• Lemaire V, Koehl M, Le Moal M, Abrous D N (2000) Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci U S A 97: 11032-11037.
• Lipska BK, Weinberger DR (2000) To Model a Psychiatric Disorder in Animals: Schizophrenia As a Reality Test. Neuropsychopharmacology 23: 223-239.
• Lodge DJ, Grace AA (2009) Gestational methylazoxymetha- nol acetate administration: a developmental disruption model of schizophrenia. Behav Brain Res 204(2): 306¬312.
• Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275.
• Lucas MM, Lenck-Santini PP, Holmes GL, Scott RC (2011) Impaired cognition in rats with cortical dysplasia: additional impact of early-life seizures. Brain 134(6): 1684-1693.
• Luoni A, Berry A, Calabrese F, Capoccia S, Bellisario V, Gass P, Cirulli F, Riva MA (2014) Delayed BDNF alterna¬tions in the prefrontal cortex of rats exposed to prenatal stress: Preventive effect of lurasidone treatment during adolescence. Eur Neuropsychopharmacol 24(6): 986-995
• Maćkowiak M, Bator E, Latusz J, Mordalska P, Wędzony K (2014) Prenatal MAM administration affects histone H3 methylation in postnatal life in the rat medial prefrontal cortex. Eur Neuropsychopharmacol 24(2): 271-289.
• Madhyastha S, Sekhar S, Rao G (2013) Resveratrol improves postnatal hippocampal neurogenesis and brain derived neurothropic factor in prenatally stressed rats. Int J Dev Neurosci 31: 580-585.
• Manahan-Vaughan D, von Haebler D, Winter C, Juckel G, Heinemann U (2008) A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus 18(2): 125-134.
• McEwen BS (2008) Central effects of stress hormones in health and disease: understanding the protective and dam¬aging effects of stress mediators. Eur J Pharmacol 583: 174-185.
• Moore H, Jentsch JD, Ghajarnia M, Geyer MA, Grace AA (2006) A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: impli¬cations for the neuropathology of schizophrenia. Biol Psychiatry 60(3): 253-264.
• Morris R (1984) Development of water-maze procedure for studying spatial learning in a rat. J Neurosci Methods 11: 47-60.
• Murer MG, Yan Q, Raisman-Vozari R (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63(1): 71-124.
• Nagai T, Kitahara Y, Shiraki A, Hikita T, Taya S, Kaibuchi K, Yamada K (2010) Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: An in vivo microdialisis study. Neurosci Lett 470: 134¬138.
• Nawa H, Takahashi M, Patterson PH (2000) Cytokine and growth factor involvement in schizophrenia - support for the developmental model. Mol Psychiatry 5: 594-603.
• O'Donnell K, O'Connor TG, Glover V (2009) Prenatal stress and neurodevelopment of the child: focus on the HPA Axis and role of the placenta. Dev Neurosci 31: 285-292.
• Ohta R, Matsumoto A, Hashimoto Y, Nagao T, Mizutani M (1995) Behavioral characteristics of rats selectively bred for high and low avoidance shuttlebox response. Cong Anom 35: 223-229.
• Ohta R. Matsumoto A. Sato M, Shirota M, Nagao T, Tohei A, Taya K (2000) Postnatal behavior in hatano high- and low-avoidance rats following prenatal exposure to low- dose methylazoxymethanol. Neurotoxicol Teratol 22(3): 405-413.
• Pencea V, Bingaman KD, Wiegand SJ, Luskin MB (2001) Infusion of brain-derived neurotrophic factor into the lateral ventricle of the adult rat leads to new neurons in the parenchyma of the striatum, septum, thalamus, and hypothalamus. J Neurosci 21: 6706-6717.
• Pers K, Rajewski A (2003) Associative processes disorders in schizophrenia (in Polish). Psychiatria Polska 37(4): 615-626.
• Ratajczak P, Kus K, Jarmuszkiewicz Z, Woźniak A, Cichocki M, Nowakowska E (2013b) Influence of aripiprazole and olanzapine on behavioral dysfunctions of adolescent rats exposed to stress in perinatal period. Pharmacol Rep 65(1): 30-43.
• Ratajczak P, Woźniak A, Nowakowska E (2013 a) Animal Models of Schizophrenia - developmental preparation in rats. Acta Neurobiol Exp (Wars) 73(4): 472-484.
• Sahu SS, Madhyastha S, Rao GM (2012) Effect of prenatal stress on expression of glutathinone in neonatal rat brain. Turk Neurosurg 22: 576-582.
• Sharp T, Zetterstrom T, Ljungberg T, Ungerstedt U (1987) A direct comparison of amphetamine-induced behaviors and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res 401: 322-330.
• Sheline TI, Wang PW, Gado MH (1996) Hippocampal atro¬phy in recurrent major depression. Proc Natl Acad Sci U S A 93: 3908-3913.
• Szubert S, Florkowski A, Bobińska K (2008) Impact of stress on plasticity of brain structures and development of chosen psychiatric disorders (in Polish). Pol Merkur Lek 24: 140-162.
• Talamini LM, Koch T, Luiten PG, Koolhaas JM, Korf J (1999) Interruptions of early cortical development affect limbic association areas and social behaviour in rats; pos¬sible relevance for neurodevelopmental disorders. Brain Res 847: 105-120.
• Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT (1995) Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 52: 829-836.